Bayer Promotes Christoph Koenen to Chief Medical Officer
Bayer AG BAYNN
News
Bayer Sells Cancer Drug to Gruenenthal for Up to $431 Million
Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment
Missouri Court Grants Delay for Bayer's Roundup Settlement Hearing
Bayer CEO Rules out Group Breakup for Now — Update
Bayer Swings to Net Profit on Smaller Litigation Charges
Apollo to Buy $3.4 Billion Stake in Bayer Contraceptives Business
German DAX On Track for First Record Since January
Bayer to Consolidate Glyphosate Business Following SCOTUS Ruling
Pesticide Giant Syngenta Appoints New CEO
Bayer Shares Jump After U.S. Supreme Court Sides With Company Over Roundup Litigation
Bayer's $7.25 Billion U.S. Settlement Over Roundup Sent Back to Missouri Court
Bayer Shares Fall on Renewed Uncertainty Over $7 Billion U.S. Settlement
Bayer Shares Climb After Earnings Beat Expectations
Bayer Net Profit Surges Driven by Growth in Agricultural Division
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion — Update
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
Jeff Ubben's Inclusive Capital Sells $369 Million in Bayer Stock
Bayer Net Loss Widens on Weedkiller Litigation Charges — 2nd Update
Bayer Net Loss Widens on Weedkiller Litigation Charges — Update
United States